- Home
- LNTH vs CWEN Comparison
LNTH vs CWEN Comparison
Compare LNTH & CWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- CWEN
- Stock Information
- Founded
- LNTH 1956
- CWEN 2012
- Country
- LNTH United States
- CWEN United States
- Employees
- LNTH N/A
- CWEN N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CWEN Electric Utilities: Central
- Sector
- LNTH Health Care
- CWEN Utilities
- Exchange
- LNTH Nasdaq
- CWEN Nasdaq
- Market Cap
- LNTH 3.8B
- CWEN 3.8B
- IPO Year
- LNTH 2015
- CWEN 2013
- Fundamental
- Price
- LNTH $50.52
- CWEN $35.50
- Analyst Decision
- LNTH Buy
- CWEN Buy
- Analyst Count
- LNTH 6
- CWEN 6
- Target Price
- LNTH $74.17
- CWEN $37.17
- AVG Volume (30 Days)
- LNTH 1.4M
- CWEN 1.2M
- Earning Date
- LNTH 11-06-2025
- CWEN 11-04-2025
- Dividend Yield
- LNTH N/A
- CWEN 5.01%
- EPS Growth
- LNTH N/A
- CWEN 125.75
- EPS
- LNTH 2.39
- CWEN 2.34
- Revenue
- LNTH $1,525,933,000.00
- CWEN $1,375,000,000.00
- Revenue This Year
- LNTH N/A
- CWEN $5.03
- Revenue Next Year
- LNTH $1.98
- CWEN $13.19
- P/E Ratio
- LNTH $21.18
- CWEN $15.08
- Revenue Growth
- LNTH 1.95
- CWEN 0.81
- 52 Week Low
- LNTH $47.25
- CWEN $24.40
- 52 Week High
- LNTH $111.29
- CWEN $35.75
- Technical
- Relative Strength Index (RSI)
- LNTH 34.98
- CWEN 76.64
- Support Level
- LNTH $54.76
- CWEN $32.08
- Resistance Level
- LNTH $61.92
- CWEN $35.20
- Average True Range (ATR)
- LNTH 2.37
- CWEN 0.89
- MACD
- LNTH -0.68
- CWEN 0.32
- Stochastic Oscillator
- LNTH 3.44
- CWEN 93.65
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About CWEN Clearway Energy Inc. Class C
Clearway Energy Inc is a publicly-traded energy infrastructure investor with a focus on investments in clean energy and owner of modern, sustainable and long-term contracted assets across North America. The company segments its operations into Flexible Generation, renewables and Corporate divisions.